Regulated information* - 15 September 2008 (13.15 p.m. CEST)
In view of the market turmoil and uncertainty caused by concerns over
the American investment bank, Lehman Brothers, KBC wishes to detail
its risk exposure to Lehman Brothers.
As of this morning, KBC's risk exposure on Lehman was as follows:
- Bonds purchased: 145 million EUR
- Credit facilities outstanding: 85 million EUR (of which 30
million EUR secured)
Moreover, there is some indirect exposure included in the underlying
assets of the CDOs in which KBC has invested. Stress tests are
currently being run to compute the exact value at risk. The impact is
expected to be below 50 million EUR.
Finally, KBC has a payment obligation towards Lehman Brothers, which
is secured by collateral and results from professional transactions.
The mark-to-market value accrued in favour of Lehman amounts to
approximately 200 million EUR.
* This news item contains information that is subject to the
transparency regulations for listed companies.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.